Dimerix has reached a key milestone by enrolling the first paediatric patient aged 12-17 in its ACTION3 Phase 3 trial for DMX-200, advancing its potential treatment for childhood FSGS kidney disease.
Advance Metals Limited has entered binding agreements to acquire significant interests in high-grade gold projects in Victoria, Australia, and a major silver project in Durango, Mexico, expanding its precious metals portfolio amid record metal prices.
